Evidence-Based Medicine
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jul 26, 2024; 12(21): 4673-4679
Published online Jul 26, 2024. doi: 10.12998/wjcc.v12.i21.4673
Surgical treatment of liver cancer and pancreatic cancer under the China Healthcare Security Diagnosis Related Groups payment system
Yun-He Hu, Fan Yu, Yu-Zhuo Zhou, Ai-Dong Li
Yun-He Hu, Fan Yu, Yu-Zhuo Zhou, Ai-Dong Li, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Author contributions: Hu YH, Yu F, Zhou YZ and Li AD contributed equally to this work; Hu YH and Li AD were the guarantors of the integrity of the entire study; Hu YH performed the study concept and design; Hu YH, Yu F, Zhou YZ prepared and wrote the manuscript; all authors have access to the data and played a role in writing this manuscript.
Supported by Research Center for Capital Health Management and Policy, No. 2024JD09.
Conflict-of-interest statement: Dr. Li has nothing to disclose.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ai-Dong Li, Associate Research Scientist, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan South Lane, Chaoyang District, Beijing 100021, China. aidong_li1208@sina.com
Received: April 30, 2024
Revised: June 6, 2024
Accepted: June 7, 2024
Published online: July 26, 2024
Processing time: 62 Days and 10.5 Hours
Core Tip

Core Tip: To analyze cost differences and their influencing factors in surgical treatments for liver and pancreatic cancer within the China Healthcare Security Diagnosis Related Groups (CHS-DRG) payment system, this study aims to examine the appropriateness of the current diagnosis-related groups groupings and provide recommendations for improvement. The CHS-DRG payment system has shown a positive impact on the surgical treatment of liver and pancreatic cancer by enhancing medical quality and managing costs. However, additional research is necessary to refine the grouping system and ensure its continued effectiveness and sustainability.